Southeast Asian startup leverages generative AI to simplify complex health data
A startup based in Malaysia and Singapore is coming up with a platform that leverages generative AI to simplify complex health data into comprehensible content.
Based on a press release, SayHeart has developed an algorithm that can seamlessly translate medical jargon, health reports, and complex imaging into "visual...
Johnson & Johnson has landed FDA clearance for a new contact lens technology developed to combat childhood myopia called Abiliti Overnight Therapeutic Lenses.
The tool uses fitting software that can accurately assess the corneal topography, refraction error and other measurements. According to J&J, the provider-facing software was developed to be user-friendly and help the clinician...
Throughout the coronavirus pandemic, healthcare companies have begun using new digital tools to help keep patients healthy. From virus-tracking APIs to remote monitoring, healthcare stakeholders are discovering just how important digital tools and strategies can be.
Having an effective digital strategy is different for each business, but it “largely consists of the organized use of tools and...
Pharma giant Johnson & Johnson is teaming up with Alevo Technologies on a new at-home diagnostic testing platform. The new tool, called the Alveo b.well, will be built to detect viral disease — which may one day include coronavirus detection. According to a release from the company, the product will include an analyzer, nasal swabs and cartridges for the detection of a virus. Consumers can...
Apple and Johnson & Johnson announced this morning the launch of their new digital health study exploring the impact of Apple’s devices and a study-specific engagement program on cardiovascular outcomes among the Medicare population.
First announced in early 2019, the Heartline Study — which also names Evidation Health as a collaborator — is now enrolling seniors aged 65 years or older who...
Due to the promises of lower costs, simple scaling and greater patient engagement, digital technologies are all but an inevitability for the drug trials of tomorrow, according to experts from pharma and the clinical research community speaking this weekend at the American Heart Association Scientific Sessions in Philadelphia.
These comments were accompanied by the official kickoff of CHIEF-HF,...
In the world of healthcare there are many stakeholders: hospitals and other providers, insurers and other payers, and, of course pharma and medical device companies. But one thing all these stakeholders have in common is that they’re increasingly moonlighting as investors.
At the kickoff of Health 2.0’s Venture Connect event today in Santa Clara, California, three of these strategic investors —...
Since it was first announced, fans and critics of the FDA’s Pre-Cert program for medical software developers have mused on the benefits and burdens that might come with participation in the experimental program.
What to expect from Pre-Cert
The question has only become more pertinent since the agency released its 1.0 Working Model in January and, just a couple weeks ago, began seeking new De Novo...
Earlier today, Johnson & Johnson announced plans for a multi-year research program it will be launching with Apple to explore the role Apple Watches could play in senior health monitoring.
Set to kickoff later this year, the pragmatic randomized controlled trial study will be conducted in the US and enroll adults aged 65 years or older, according to a statement. Specifically, the primary...
By and large, Q3 2018 was a slow and steady quarter for pharma moves in digital health, at least in terms of publicly disclosed operations. At events during the quarter, the likes of Johnson & Johnson, AstraZeneca, Novartis and Sanofi discussed digital therapeutics and expressed a healthy mixture of skepticism and enthusiasm for the space.
“These technologies have a tremendous opportunity to...
